For colorectal cancer, it has been demonstrated that PDPN-positive CAF phenotype was associated with less aggressive tumors, whereas PDPN-low/α-SMAhigh or PDPN-low/S100A4high CAFs were associated with tumor progression [17]. This evidence concerns the gene PDPN and colorectal cancer.